Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket studyFunda Meric‐Bernstam, John D. Hainsworth, Howard A. Burris et al.|The Lancet Oncology|2019Cited by 564
Efficacy analysis of MASTERKEY-265 phase 1b study of talimogene laherparepvec (T-VEC) and pembrolizumab (pembro) for unresectable stage IIIB-IV melanoma.Georgina V. Long, F. Stephen Hodi, Reinhard Dummer et al.|Journal of Clinical Oncology|2016Cited by 110
<i>NRG1</i> fusions in solid tumors.Brinda Gupta, Stephen V. Liu, Sharon Wu et al.|Journal of Clinical Oncology|2023Cited by 7
PP01.14 Paired Sample Analyses of NSCLC After SCLC TransformationBrinda Gupta, Stephen V. Liu, Kieran Sweeney et al.|Journal of Thoracic Oncology|2025Cited by 0